Translational Research: Crossing Over the Valley of Death
FasterCures published Crossing Over the Valley of Death, the first comprehensive report that catalogued the challenges in translational research, articulated real-world case studies that demonstrated the critical value of this phase in the therapeutic development process, and pointed the way toward solutions.
Highlights models of collaboration in early-stage R&D, lessons learned from them, and potential broader applications of these existing models.
The biopharmaceutical industry needs novel approaches to early-stage drug development that better manage risk, lower capital cost and improve research effectiveness, create diverse portfolios, leverage risk-tolerant capital, and access new capital sources. With these issues in mind, the Milken Institute and FasterCures hosted a Financial Innovations Lab on July 19, 2011, in New York City. The Lab was convened to address an industry-wide gap in funding for early-stage drug development—the so-called Valley of Death. This report, Fixes in Financing: Financial Innovations for Translational Research, highlights various approaches for managing and financing translational research that were discussed during the Lab.